AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2010

Mar 12, 2010

33819_dirs_2010-03-12_f99dcf2d-c694-4584-98d0-e2393610013f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2010-03-10

Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-10	Common Stock	F	32092	$1.22	Disposed	198741	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22834	Indirect
Common Stock	42080	Indirect

Footnotes

F1: Includes (1) 93,333 restricted stock units, with 1/4 vesting on each of the four anniversaries following the May 15, 2009 grant date and (2) 68,750 restricted stock units, vesting on March 10, 2011.

F2: 22,834 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership.

F3: Shares held in 401(k) account, in accordance with issuer's employer-match policies.